Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) cut to hold at DZ Bank

0

Fresenius Medical Care AG & Co. KGaA (NYSE: FMS – Get a rating) was downgraded by stock analysts DZ Bank from a “buy” rating to a “hold” rating in a research report released on Friday, Fly reports.

A number of other equity research analysts have also recently released reports on the stock. Truist Financial cut its price target on shares of Fresenius Medical Care AG & Co. KGaA from $34.00 to $27.00 and set a “hold” rating for the company in a Wednesday 22 research note. June. JPMorgan Chase & Co. raised its price target on shares of Fresenius Medical Care AG & Co. KGaA from €48.70 ($49.69) to €51.00 ($52.04) and assigned the company an “underweight” rating in a Thursday, May 5, research report. . Jefferies Financial Group downgraded shares of Fresenius Medical Care AG & Co. KGaA from an “underperform” rating to a “buy” rating and raised its price target for the company from $30.30 to 33, $70 in a Monday, June 27 research report. StockNews.com cut shares of Fresenius Medical Care AG & Co. KGaA from a “strong buy” rating to a “buy” rating in a Friday, July 15 research report. Finally, UBS Group downgraded shares of Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “neutral” rating in a research report released on Friday. One research analyst gave the stock a sell rating, eight issued a hold rating and four issued a buy rating. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $52.51.

Pricing performance of Fresenius Medical Care AG & Co. KGaA

A d ProTrading Research

Buy the bear market…

Investors have seen their assets lose value… So what should you do when this happens? We say “BUY”… But don’t guess your way… Click here to see my top 3 opportunities.

NYSE:FMS shares opened at $18.28 on Friday. Fresenius Medical Care AG & Co. KGaA has a one-year low of $22.06 and a one-year high of $41.38. The company has a market capitalization of $10.71 billion, a price/earnings ratio of 11.04, a PEG ratio of 0.95 and a beta of 1.21. The company’s fifty-day moving average price is $25.76 and its 200-day moving average price is $30.24. The company has a debt ratio of 0.51, a current ratio of 1.26 and a quick ratio of 0.93.

Fresenius Medical Care AG & Co. KGaA (NYSE: FMS – Get a rating) last reported quarterly earnings data on Wednesday, May 4. The company reported earnings per share (EPS) of $0.38 for the quarter, beating consensus analyst estimates of $0.30 by $0.08. Fresenius Medical Care AG & Co. KGaA achieved a net margin of 4.91% and a return on equity of 6.99%. The company posted revenue of $5.10 billion in the quarter, compared to $4.97 billion expected by analysts. On average, stock research analysts expect Fresenius Medical Care AG & Co. KGaA to post 1.82 earnings per share for the current fiscal year.

Institutional trading of Fresenius Medical Care AG & Co. KGaA

A number of institutional investors have recently changed their positions in the stock. National Bank of Canada FI increased its holdings of Fresenius Medical Care AG & Co. KGaA shares by 11,054.0% in the second quarter. National Bank of Canada FI now owns 16,731 shares of the company worth $417,000 after purchasing an additional 16,581 shares in the last quarter. Wulff Hansen & CO. increased its equity stake in Fresenius Medical Care AG & Co. KGaA by 37.2% in the second quarter. Wulff Hansen & CO. now owns 14,832 shares of the company worth $370,000 after purchasing an additional 4,018 shares in the last quarter. Commonwealth Equity Services LLC increased its holdings of Fresenius Medical Care AG & Co. KGaA shares by 5.5% in the second quarter. Commonwealth Equity Services LLC now owns 14,070 shares of the company worth $350,000 after purchasing an additional 736 shares in the last quarter. Valley National Advisers Inc. increased its equity stake in Fresenius Medical Care AG & Co. KGaA by 5.0% in the second quarter. Valley National Advisers Inc. now owns 31,886 shares of the company worth $775,000 after purchasing an additional 1,515 shares in the last quarter. Finally, Timber Creek Capital Management LLC increased its equity stake in Fresenius Medical Care AG & Co. KGaA by 0.3% in the second quarter. Timber Creek Capital Management LLC now owns 199,285 shares of the company worth $4,970,000 after purchasing an additional 542 shares in the last quarter. Hedge funds and other institutional investors own 4.73% of the company’s shares.

Fresenius Medical Care AG & Co. KGaA Company Profile

(Get a rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Further reading

The Fly logo

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)

This instant news alert was powered by MarketBeat’s storytelling science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Should you invest $1,000 in Fresenius Medical Care AG & Co. KGaA right now?

Before you consider Fresenius Medical Care AG & Co. KGaA, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes a turn… and Fresenius Medical Care AG & Co. KGaA was not on the list.

While Fresenius Medical Care AG & Co. KGaA currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here

Share.

Comments are closed.